Global Generic Drugs Market: Poised for USD 615.72 Billion Milestone by 2030 at 5.22% CAGR

𝐆𝐥𝐨𝐛𝐚𝐥 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐀 𝐏𝐫𝐨𝐦𝐢𝐬𝐢𝐧𝐠 𝐆𝐫𝐨𝐰𝐭𝐡 𝐓𝐫𝐚𝐣𝐞𝐜𝐭𝐨𝐫𝐲 𝐰𝐢𝐭𝐡 𝐊𝐞𝐲 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

The Global Generic Drugs Market was valued at USD 439.37 billion in 2023 and is projected to grow at a CAGR of 6.2% from 2024 to 2030, reaching an estimated value of USD 669.58 billion by the end of the forecast period. This growth is driven by increasing demand for cost-effective medications, regulatory support for generics, and an aging global population.

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲

The generic drugs market has witnessed several transformative developments, including mergers, acquisitions, and collaborations among leading pharmaceutical companies. These strategies aim to enhance market presence, broaden product portfolios, and foster innovation. Key players like 𝐓𝐞𝐯𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, 𝐌𝐲𝐥𝐚𝐧 𝐍.𝐕., 𝐒𝐮𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, 𝐚𝐧𝐝 𝐃𝐫. 𝐑𝐞𝐝𝐝𝐲'𝐬 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬 are leading the way in reshaping the competitive landscape.

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐕𝐢𝐞𝐭𝐧𝐚𝐦: 𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞

Vietnam's generic drugs market is poised for significant growth, driven by government initiatives to promote affordable healthcare. The country's pharmaceutical sector saw several mergers and partnerships, such as𝐃𝐇𝐆 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐉𝐒𝐂 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐓𝐚𝐢𝐬𝐡𝐨 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 to enhance manufacturing capabilities. Increased healthcare spending and demand for chronic disease treatments further fuel the market.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐡𝐢𝐧𝐚: 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞

China dominates the generic drugs market in Asia, driven by its vast population and government policies supporting the development of generics. Recent consolidations, such as 𝐒𝐡𝐚𝐧𝐠𝐡𝐚𝐢 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 acquiring 𝐂𝐚𝐫𝐝𝐢𝐧𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐂𝐡𝐢𝐧𝐚 underscore the sector's growth trajectory. Additionally, the "4+7 bulk procurement policy" has encouraged domestic manufacturers to scale up production and meet the growing demand for affordable medications.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝: 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞

Thailand's generic drugs market has experienced steady growth, supported by its Universal Health Coverage scheme. Partnerships like that between 𝐁𝐚𝐧𝐠𝐤𝐨𝐤 𝐃𝐮𝐬𝐢𝐭 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐚𝐧𝐝 𝐏𝐢𝐫𝐚𝐦𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 highlight efforts to expand the availability of cost-effective drugs. The market's focus on generic biologics and biosimilars is expected to drive future growth.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐉𝐚𝐩𝐚𝐧: 𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲

Japan's aging population and rising healthcare costs have spurred demand for generics. Companies like 𝐒𝐚𝐰𝐚𝐢 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐓𝐨𝐰𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 are expanding their portfolios through acquisitions. The government's policy to increase generic drug penetration to 80% by 2025 further solidifies Japan's market potential.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚: 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭

South Korea's robust R&D infrastructure supports its growing generic drugs market. Collaborations, such as 𝐂𝐞𝐥𝐥𝐭𝐫𝐢𝐨𝐧 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐓𝐞𝐯𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 underscore the country's leadership in biosimilar production. The market benefits from government incentives aimed at reducing reliance on branded drugs.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞: 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐟𝐨𝐫 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧

Singapore's strategic location and advanced healthcare infrastructure make it a hub for generic drug manufacturing and distribution. Recent investments by Pfizer and Novartis in production facilities showcase the country's potential. The government's focus on healthcare affordability continues to drive demand for generics.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬: 𝐆𝐫𝐨𝐰𝐭𝐡 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞

The U.S. remains a key player in the global generics market, with companies like 𝐌𝐲𝐥𝐚𝐧 𝐚𝐧𝐝 𝐓𝐞𝐯𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 leading the charge. Recent mergers, including Viatris (formed by Mylan and Pfizer's Upjohn), have reshaped the competitive landscape. The FDA's expedited approval process for generics bolsters market growth.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐄𝐮𝐫𝐨𝐩𝐞: 𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐔𝐩𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲

Europe's generic drugs market is characterized by strong regulatory support and a focus on biosimilars. Key developments include Sandoz (a division of Novartis) acquiring biopharmaceutical assets to strengthen its position. Countries like Germany, France, and the UK lead in adopting generics, driven by healthcare cost-containment measures.

𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧? 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐨𝐫 𝐢𝐧𝐪𝐮𝐢𝐫𝐞 𝐧𝐨𝐰 : https://www.maximizemarketresearch.com/request-sample/32316/

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐤𝐞𝐲 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 :

𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Simple Generics
Super Generics
Biosimilars

The global generic drug industry is divided into three segments based on the product: biosimilars, super generics, and simple generics. In 2023, the Super Generics category had the biggest market share, with about 38%. Super generic medications are referred to as value enhanced generics, hybrids, and unique therapeutic entities. Super generic products are not the same as the original product in terms of composition or distribution method. Although biosimilars can only be as comparable to the original branded drug as validation technology allows, they have the same clinical impact as generics. As biosimilar developers concentrate on increasingly complicated proteins that require more expensive and advanced production processes, they will be pressured to follow established methods for demonstrating a high degree of similarity.

𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Cardiovascular Products
Anti-Infective Drugs
Anti-Arthritis Drugs
Central Nervous System Drugs
Anti-Cancer Drug
Respiratory Products
Others

Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, Respiratory Products, and Others are the sub-segments of the worldwide generic drug market based on application. In 2023, the biggest market share was held by the Central Nervous System Drugs sector. Access to better healthcare options, societal acceptance of people with mental illnesses, and growing knowledge of mental health issues are some of the key factors predicted to propel market expansion. During the forecast period, cost-effective and readily available pharmaceuticals are likely to drive generic drug market growth.

𝐛𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥

Hospitals
Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
Others

One of the leading causes of death worldwide is cardiovascular disease, which includes heart failure, circulation problems, hypertension, cholesterol, dyslipidemia, angina, arrhythmias, and stroke. The cardiovascular category now makes up over 5% of the global generic medication market as a result of multiple cardiovascular medicine patents expiring. The aging demographics and expanding global population are helping the generic drug industry as well as the larger healthcare sector.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐝𝐚𝐭𝐚 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐛𝐲 𝐯𝐢𝐞𝐰𝐢𝐧𝐠 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 : @https://www.maximizemarketresearch.com/market-report/global-green-mining-market/32316/

𝐋𝐞𝐚𝐫𝐧 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐭𝐨𝐩 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 :

North America Generic Drugs Market Top Players:

1. Mylan N.V. - (USA)
2. Par Pharmaceuticals- (USA)
3. Pfizer - (USA)
4. Baxter International Inc. - (USA)
5. Eli Lilly and Company - (USA)
6. Abbott Laboratories - (USA)
7. Apotex Inc. - (Canada)
8. Apotex Corp. - (USA)

Europe Generic Drugs Market Top Players

1. Endo Pharmaceuticals - (Ireland)
2. Teva Pharmaceutical Industries Ltd- (Israel)
3. STADA Arzneimittel AG - (Germany)
4. GlaxoSmithKline Plc. - (United Kingdom)
5. Novartis International AG - (Switzerland)

APAC Generic Drugs Market Top Players:

1. Sun Pharma - (India)
2. Lupin Pharmaceuticals - (India)
3. Dr Reddy's - (India)
4. ASKA Pharmaceutical Co., Ltd. - (Japan)
5. Taisho Pharmaceutical Holdings Co Ltd - (Japan)
6. Aurobindo Pharma Limited - (India)
7. Hikma Pharmaceuticals PLC - (Jordan)
8. Torrent Pharmaceuticals Ltd - (India)

𝐆𝐞𝐭 𝐚𝐧𝐬𝐰𝐞𝐫𝐬 𝐭𝐨 𝐜𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 :

What is Generic Drugs ?
What is the growth rate of the Generic Drugs Market?
Which are the factors expected to drive the Generic Drugs market growth?
What is the CAGR at which the Generic Drugs market will grow during the forecast period?
What are the different segments of the Generic Drugs Market?
Which is the fastest growing region in the Generic Drugs market?
What growth strategies are the players considering to increase their presence in Generic Drugs ?
What are the upcoming opportunities and trends for the Generic Drugs Market?
What are the recent industry trends that can be implemented to generate additional revenue streams for the Generic Drugs Market?
Who are the leading companies and what are their portfolios in Generic Drugs Market?
What segments are covered in the Generic Drugs Market?
Who are the key players in the Generic Drugs market?

𝐆𝐚𝐢𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐯𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐥𝐢𝐧𝐤 @https://www.maximizemarketresearch.com/request-sample/32316/

𝐆𝐞𝐭 𝐚 𝐜𝐥𝐨𝐬𝐞𝐫 𝐥𝐨𝐨𝐤 𝐚𝐭 𝐭𝐡𝐞 𝐠𝐚𝐦𝐞-𝐜𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐬𝐮𝐜𝐜𝐞𝐬𝐬.

Past Size and Competitive Landscape
• Past Pricing and price curve by region
• Size, Share, Size Forecast by different segment
• Dynamics Growth Drivers, Restraints, Opportunities, and Key Trends by Region
• Segmentation A detailed analysis by segment with their sub-segments and Region
• Competitive Landscape Profiles of selected key players by region from a strategic perspective

𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐨𝐮𝐫 𝐭𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 𝐭𝐨 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐬𝐡𝐢𝐟𝐭𝐬 :

♦ global Chatbots Market https://www.maximizemarketresearch.com/market-report/global-chatbots-market-key-trends/7204/

♦ global Dietary Supplements Market https://www.maximizemarketresearch.com/market-report/global-dietary-supplements-market/26277/

♦ Infant Formula Market https://www.maximizemarketresearch.com/market-report/infant-formula-market/124801/

♦ Industrial Hemp Market https://www.maximizemarketresearch.com/market-report/global-industrial-hemp-market/33440/

♦ Global Gaming Market https://www.maximizemarketresearch.com/market-report/global-gaming-market/44697/

♦ US Artificial Intelligence (AI) Market https://www.maximizemarketresearch.com/market-report/us-artificial-intelligence-ai-market/11352/

♦ Microcrystalline Cellulose Market https://www.maximizemarketresearch.com/market-report/microcrystalline-cellulose-market/13475/

♦ Global Agricultural Micronutrients Market https://www.maximizemarketresearch.com/market-report/global-agricultural-micronutrients-market/50434/

♦ Global Automatic Train Control Market https://www.maximizemarketresearch.com/market-report/global-automatic-train-control-market/29767/

♦ Geospatial Solutions Market https://www.maximizemarketresearch.com/market-report/global-geospatial-solutions-market/61529/

𝐑𝐞𝐚𝐜𝐡 𝐎𝐮𝐭 𝐭𝐨 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐟𝐨𝐫 𝐈𝐧-𝐃𝐞𝐩𝐭𝐡 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 :

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
sales@maximizemarketresearch.com
www.maximizemarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.